Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $152.56 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $48.07 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $29.59 | 2 | $0 (2023) |
| PFIZER INC. | $26.46 | 2 | $0 (2022) |
| Exact Sciences Corporation | $26.07 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $22.37 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43.28 | 2 | Exact Sciences Corporation ($26.07) |
| 2023 | $60.45 | 4 | Amgen Inc. ($30.86) |
| 2022 | $14.92 | 1 | PFIZER INC. ($14.92) |
| 2020 | $11.54 | 1 | PFIZER INC. ($11.54) |
| 2018 | $22.37 | 2 | Novartis Pharmaceuticals Corporation ($22.37) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Oncology | ||||||
| 10/30/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Inflammation | ||||||
| 10/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Cardio-renal | ||||||
| 10/03/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Inflammation | ||||||
| 10/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Cardio-renal | ||||||
| 10/03/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/28/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/27/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 182 | 246 | $33,985 | $17,894 |
| 2022 | 11 | 1,050 | 1,325 | $215,779 | $115,685 |
| 2021 | 10 | 1,059 | 1,326 | $194,622 | $118,348 |
| 2020 | 8 | 918 | 1,079 | $190,880 | $106,575 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 59 | 116 | $10,677 | $6,112 | 57.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 51 | 53 | $7,736 | $4,284 | 55.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 40 | $7,176 | $3,448 | 48.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $5,772 | $2,493 | 43.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 17 | $2,624 | $1,557 | 59.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 255 | 492 | $51,951 | $28,928 | 55.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 297 | 314 | $53,793 | $28,186 | 52.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 180 | 186 | $36,779 | $20,529 | 55.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 120 | 121 | $35,740 | $18,937 | 53.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 68 | 79 | $12,892 | $6,694 | 51.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 16 | 17 | $7,595 | $3,164 | 41.7% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 29 | 29 | $6,104 | $2,994 | 49.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 42 | 44 | $4,521 | $2,421 | 53.5% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $3,466 | $2,153 | 62.1% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 13 | 13 | $1,564 | $869.71 | 55.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 15 | 15 | $1,373 | $808.72 | 58.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 335 | 348 | $51,650 | $31,637 | 61.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 268 | 489 | $44,700 | $29,693 | 66.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 138 | 139 | $38,404 | $21,753 | 56.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 150 | 153 | $29,752 | $17,159 | 57.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 96 | 124 | $16,201 | $10,875 | 67.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 13 | 13 | $6,380 | $2,311 | 36.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 13 | 13 | $3,058 | $1,952 | 63.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 23 | 24 | $2,261 | $1,456 | 64.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 12 | 12 | $1,130 | $759.84 | 67.2% |
About Dr. Adrien Tanenbaum, M.D
Dr. Adrien Tanenbaum, M.D is a Internal Medicine healthcare provider based in West Milford, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1851670129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adrien Tanenbaum, M.D has received a total of $152.56 in payments from pharmaceutical and medical device companies, with $43.28 received in 2024. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($152.56).
As a Medicare-enrolled provider, Tanenbaum has provided services to 3,209 Medicare beneficiaries, totaling 3,976 services with total Medicare billing of $358,502. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location West Milford, NJ
- Active Since 08/04/2011
- Last Updated 10/04/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851670129
Products in Payments
- Otezla (Drug) $30.86
- Kerendia (Drug) $29.59
- ELIQUIS (Drug) $26.46
- Cologuard Collection Kit (Device) $26.07
- ENTRESTO (Drug) $22.37
- Repatha (Biological) $17.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.